Prevention of Post COVID-19 Condition by Early Treatment with Ensitrelvir in the Phase 3 SCORPIO-SR Trial. Yotsuyanagi H, Ohmagari N, Doi Y, Yamato M, et al. Antiviral Res 2024 Jul 5:105958. doi: 10.1016/j.antiviral.2024.105958.

Read + Share

Amedeo Smart

Independent Medical Education

Yotsuyanagi H, Ohmagari N, Doi Y, Yamato M, et al. Prevention of Post COVID-19 Condition by Early Treatment with Ensitrelvir in the Phase 3 SCORPIO-SR Trial. Antiviral Res 2024 Jul 5:105958. doi: 10.1016/j.antiviral.2024.105958.
PMID: 38972603